Leading-edge healthcare challenge

Serum processing for the COVID-19 vaccine

The leading-edge healthcare challenge, with a funding investment of £181 million in total, focuses on accelerating the development and manufacture of new medicines and treatments. The challenge includes two research programmes:

  • Medicines Manufacturing
  • Digital Health Technology Catalyst.

Medicines Manufacturing programme

This programme includes four major infrastructure projects:

UK businesses can get funding through Medicines Manufacturing collaborative research and development funding competitions. These support research and innovation projects that improve manufacturing, scale up production and lower costs.

Additionally, the programme includes a £25 million fund for collaborative research and development in medicines manufacturing, which was set up in 2017 to run for four years. Aims included:

  • improving commercial viability
  • developing methods for scale-up
  • increasing the process yield
  • lowering the cost of production.

Read more about business funding opportunities and networking.

Digital Health Technology Catalyst

This £35 million fund was set up in 2017 and will run for four years.

It aims to address challenges in the development of digital health innovations and to grow the digital health sector.

Project case study: Biotech startup launches app to help people with type 1 diabetes dose insulin (Cambridge Network)

Project case study: Patients with COPD offered new tools to manage condition at home (NHS Greater Glasgow and Clyde)

Last updated: 11 November 2021

NOTE Council web content is being transitioned to this website – let us know if you have feedback or would like to help us test new developments.